Stay updated on Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page adds a recruitment-status notice and new user guidance sections, along with a UI revision note indicating the version change.
    Difference
    0.1%
    Check dated 2026-06-12T00:29:00.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.5.5, replacing the previous v3.5.4. This indicates a version update of the page content rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-05T00:40:58.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page's revision tag has been updated to v3.5.4, replacing the previous v3.5.3. This reflects a small, non-content-related update to the page version.
    Difference
    0.0%
    Check dated 2026-05-21T17:46:24.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.5.3, replacing the previous Revision: v3.5.2, indicating a content update.
    Difference
    0.0%
    Check dated 2026-04-30T08:48:44.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-15T22:09:38.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T06:59:28.000Z thumbnail image

Stay in the know with updates to Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.